ANGPT1 and breast cancer: Makhoul et al. showed that ANGPT1 rs2445365 was linked to a pathologic complete response (pCR) in their prospective phase II study of the use of bevacizumab as neoadjuvant to chemotherapy in breast cancer patients [24].